ArdeoGraft® is a cutting-edge dual layer allograft derived from chorion, designed for wound care applications. This advanced product acts as a protective barrier, offering exceptional coverage and shielding acute and chronic wounds from the surrounding environment.
ArdeoGraft® provides optimal protection and retains a moist environment.
ArdeoGraft® is processed in compliance with the United States Food and Drug Administration current Good Tissue Practices (cGTP) Regulations and the American Association of Tissue Banks Standards. We pride ourselves on quality and testing that meet industry standards.
ArdeoGraft® provides a protective barrier and aids in the development of granulation tissue in acute and chronic closures.
ArdeoGraft® is regulated under Section 361 of the PHS Act and FDA 21 CFR Part 1271 and is intended for homologous use.
HCPCS Level II Code Q4333, "ArdeoGraft, per square centimeter"
Immunogenicity
The chorion membrane has unique non-immunological properties. Reference
Human Extracellular Matrix (ECM)
The membrane sheet provides a protective covering that may aid in wound management. Reference
Barrier
The extracellular matrix acts as a barrier that may potentiate the migration and adhesion of resident cells. Reference
